Predictors of Survival 1 Hour After Implantation of an Intra-aortic Balloon Pump in Cardiac Surgery

Hausmann, Harald; Potapov, Evgenij; Koster, Andreas; Siniawski, Henryk; Kukucka, Marian; Loebe, Matthias; Krabatsch, Thomas; Sodian, Ralf; Yeter, R.; Kuppe, Hermann; Hetzer, Roland

doi:10.1111/j.1540-8191.2001.tb00486.x

Cited by 44 publications

(69 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…3,9,18,22 Cardiac failure appears to be relevant only in the first post-operative days, when it is described as postcardiotomy cardiogenic shock. 19 However, a protracted inflammatory response with high catecholamine dependency after cardiac surgery could also lead to other organ failures, such as ARF-D and respiratory failure. 5 -7 Measures to reduce the risk of cardiac and non-cardiac organ failures should therefore be taken throughout the entire hospital stay, ideally early on or as a pre-operative preventive measure.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Intensive Care Unit Stay of More than 14 Days after Cardiac Surgery is Associated with Non-cardiac Organ Failure

et al. 2006

View full text Add to dashboard Cite

Some studies have shown an association between a prolonged intensive care unit (ICU) stay and risk factors such as mediastinal re-exploration, advanced age, low ejection fraction, lung disease and organ failure. The aim of this retrospective study was first to evaluate peri-operative risk factors (n = 2683) and secondly to evaluate long-term survival (n = 2563) in cardiac surgery patients with an ICU stay > 14 days. Long-term survival was assessed in an observational 3-year follow-up study. An ICU stay of > 14 days was associated independently with respiratory failure and dialysis-dependent acute renal failure, and with a significantly lower survival rate. Since an ICU stay is associated with a higher hospital and long-term mortality, measures should be taken throughout the entire hospital stay to identify and reduce the risk of organ failure.

show abstract

Section: Discussionmentioning

confidence: 99%

“…In patients whose ICU stay was > 14 days, the stay was shorter in the patients with a VAD (median [25% quartile, 75% quartile], 23 [19,37]) days) than in those without (28 [21,40] …”

Section: Univariate and Multivariate Analysesmentioning

confidence: 99%

Intensive Care Unit Stay of More than 14 Days after Cardiac Surgery is Associated with Non-cardiac Organ Failure

et al. 2006

View full text Add to dashboard Cite

show abstract

“…63,64 This state may be attributable to low cardiac output (a result in part of myocardial hibernation, stunning, or inadequate cardioprotection), systemic vasodilation, or both. [63][64][65] If these common causes of CS are not consistent with the presentation, then less common causes listed in Supplemental Table 1 should be considered. In acute e236 myocarditis, paradoxically, the sickest patients on presentation have the best odds of recovery, particularly in younger age groups.…”

Section: Pathogenesismentioning

confidence: 99%

Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association

Diepen¹,

Katz²,

Albert³

et al. 2017

Circulation

1,343

1,165

View full text Add to dashboard Cite

Cardiogenic shock is a high-acuity, potentially complex, and hemodynamically diverse state of end-organ hypoperfusion that is frequently associated with multisystem organ failure. Despite improving survival in recent years, patient morbidity and mortality remain high, and there are few evidence-based therapeutic interventions known to clearly improve patient outcomes. This scientific statement on cardiogenic shock summarizes the epidemiology, pathophysiology, causes, and outcomes of cardiogenic shock; reviews contemporary best medical, surgical, mechanical circulatory support, and palliative care practices; advocates for the development of regionalized systems of care; and outlines future research priorities. Cardiogenic shock (CS) is a low-cardiac-output state resulting in life-threatening end-organ hypoperfusion and hypoxia.1,2 Acute myocardial infarction (MI) with left ventricular (LV) dysfunction remains the most frequent cause of CS. 1,3 Advances in reperfusion therapy have been associated with improvements in survival, but significant regional disparities in evidence-based care have been reported, and in-hospital mortality remains high (27%-51%).1,4-9 Management recommendations are distributed between disease-specific statements and guidelines, and a dedicated and comprehensive clinical resource in this area is lacking. Thus, consolidating the evidence to define contemporary best medical and surgical CS practices for both MI-associated CS and other types of CS may be an important step in knowledge translation to help attenuate disparities in evidence-based care.Regional systems of care coupled with treatment algorithms have improved survival in high-acuity time-sensitive conditions such as MI, out-of-hospital cardiac arrest (OHCA), and trauma.10-12 Applying a similar framework to CS management may lead to similar improvements in survival, and CS systems of care are emerging within existing regional cardiovascular emergency care networks; however, guidance from a national expert group on structure and systems of care has not been available. 13,14 Accordingly, the purposes of this American Heart Association (AHA) scientific statement on CS are to summarize our contemporary understanding of the epidemiology, pathophysiology, and in-hospital best care practices into a single clinical resource document; to suggest a stepwise management algorithm that integrates medical, surgical, and mechanical circulatory support (MCS) therapies; and to propose a Mission: Lifelinesupported pathway for the development of integrated regionalized CS systems of care. DEFINITION OF CSAcute cardiac hemodynamic instability may result from disorders that impair function of the myocardium, valves, conduction system, or pericardium, either in isolation HISTORICAL PERSPECTIVESBefore the routine use of early revascularization, MIassociated CS had an in-hospital mortality exceeding 80%. A registry trial of 250 patients with acute MI described the association between bedside physical examination (Killip classification) for the as...

show abstract

“…IAB has been recommended for patients with obstruction of left coronary branch 165 in mitral insufficiency in a condition of postoperative low output 166 . In patients whose signs of left ventricular dysfunction and tissue hypoperfusion are intense since the beginning, or in where the IAB failed to restore tissue perfusion, the implant of artificial ventricular support must be considered 167,168 .…”

Section: Cardiac Surgeriesmentioning

confidence: 99%

I Diretriz Latino-Americana para avaliação e conduta na insuficiência cardíaca descompensada

Bocchi¹,

Vilas-Boas²,

Perrone³

et al. 2005

Arq. Bras. Cardiol.

View full text Add to dashboard Cite

Predictors of Survival 1 Hour After Implantation of an Intra-aortic Balloon Pump in Cardiac Surgery

Cited by 44 publications

References 22 publications

Intensive Care Unit Stay of More than 14 Days after Cardiac Surgery is Associated with Non-cardiac Organ Failure

Intensive Care Unit Stay of More than 14 Days after Cardiac Surgery is Associated with Non-cardiac Organ Failure

Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association

I Diretriz Latino-Americana para avaliação e conduta na insuficiência cardíaca descompensada

Contact Info

Product

Resources

About